Evaluation of Colon-Specific Plasma Nanovesicles as New Markers of Colorectal Cancer
C:/Users/julia/biotechnologische Studenteninitiative (btS) e.V/Leipzig - ScieGuide 2019/ScieGuide final 08.08/ScieGuide070819.sl
PEI-complexed LNA antiseeds as miRNA inhibitors
Mitarbeiter des Rudolf-Boehm-Institutes
Therapeutic siRNA: State-of-the-Art and Future Perspectives | SpringerLink
Drug Delivery by Ultrasound-Responsive Nanocarriers for Cancer Treatment
SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC) | Scientific Reports
Mitarbeiter des Rudolf-Boehm-Institutes
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma
Programme – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Vorlage Geschäftsbrief mit Siegel
Multiple effects of the special ATâ•'rich binding protein 1 (SATB1) in colon carcinoma
Inhalt. Transparenz. Forschen Lehren Heilen. Struktur & Prozess Menschen. Wichtige Kennzahlen Leistungsdaten. Einrichtungen & Ansprechpartner - PDF Free Download
SATB1-Mediated Upregulation of the Oncogenic Receptor Tyrosine Kinase HER3 Antagonizes MET Inhibition in Gastric Cancer Cells
Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects | Scientific Reports
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Mitarbeiter des Rudolf-Boehm-Institutes
Cell-type specific and non-redundant anti-proliferative effects of shRNA-mediated Galpha12- and Galpha13 knockdown in lung canc
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Achim Aigner | Leipzig University, Germany | Pharmaceutica 2017 | Conferenceseries
Accommodation – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
فلسفي دافئ تحويلات بند تشابه لفة aigner et al 2011 - afsassociation.org
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo: Molecular Therapy - Nucleic Acids
Polyethylenimine Nanoparticle-Mediated siRNA Delivery to Reduce α-Synuclein Expression in a Model of Parkinson's D
Curriculum vitae
